m+Medelevator.RU
← Поиск публикаций
Reproductive sciences (Thousand Oaks, Calif.) · 2025

Endometrial Cell Senescence and Recurrent Spontaneous Abortion: Biomarker Potential of UCP2 and GSR.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Chen Zhumei, Fang Fuzhen, Zhang Yan, Huang Xiaohai, Huang Jianhuang

Аннотация

This study explores the molecular mechanisms driving recurrent spontaneous abortion, a condition affecting 1-5% of women of reproductive age, with 40-50% of cases unexplained. Focusing on endometrial cell senescence, a process linked to irreversible cell cycle arrest, the research identifies uncoupling protein 2 (UCP2) and glutathione reductase (GSR) as key contributors to this pathology. By analyzing transcriptome data from the Gene Expression Omnibus database, 21 genes associated with cellular senescence were found to be differentially expressed, with UCP2 and GSR significantly upregulated. These findings were validated using a hydrogen peroxide-induced senescence model in human endometrial stromal cells. Diagnostic potential was confirmed through receiver operating characteristic curve analysis, showing promising results for both UCP2 and GSR. The study also observed increased activity of natural killer and T cells in affected tissues, pointing to an immune component in recurrent spontaneous abortion. Drug prediction analysis highlighted dexamethasone and menadione as potential treatments. These insights suggest that oxidative stress-induced senescence plays a critical role in recurrent spontaneous abortion, with UCP2 and GSR as promising biomarkers and therapeutic targets to improve endometrial health and reduce miscarriage risk. Further clinical studies are needed to validate these findings and explore their therapeutic applications.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты